posted
I don't know if anyone has seen this, but if Calba Tech is the company they appear to be, this report should reflect it. This report should be reviewed by institutional investors and big money individuals. I haven't read it, so I don't have any insight as to it's content. If the report is positive for Calba Tech, hang on!
September 07, 2006 10:40 AM US Eastern Timezone View the Recent Industry Activity within the Cell/Tissue Culture Supplies Market DUBLIN, Ireland--(BUSINESS WIRE)--Sept. 7, 2006--Research and Markets (http://www.researchandmarkets.com/reports/c41686) has announced the addition of Cell/Tissue Culture Supplies - Global Strategic Business Report to their offering.
This report analyzes the worldwide markets for Cell/Tissue Culture Supplies in Millions of US$. The specific product segments analyzed are Media, Sera, and Reagents. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin America. Annual forecasts are provided for each region and product segment for the period of 2000 through 2010. The report profiles 113 companies including many key and niche players worldwide.
Contents Include:
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
II. 1. Market Dynamics 2. Trends and Issues 3. End Use Analysis 4. Cell/Tissue Culture: Physiological Overview 5. Regulatory Environment 6. Product Introductions/Innovations 7. Recent Industry Activity 8. Focus on Select Major Players 9. Global Market Perspective
III. MARKET 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America
IV. COMPETITION
Some Companies Mentioned inside the report include:
posted
the above post was taken from another member on another board that I found very interesting.CLBE is going to go nuts once the announcement hits about the coast to coast microbank openings.
posted
Today’s Price Performance as of 12:39pm EDT, 9/08/2006 Option Chains Margin Requirements Interactive Chart
Loading Chart1 Day | 5 Day | 6 Mo | 1 Yr | 3 Yr | 5 Yr $0.05 Last Price 0.0050 -9.09% Today’s Change $0.06 Today’s Open 110,367 Below Avg. Today’s Volume
-------------------- All I say is IMHO.
I like these calm little moments before the storm... Reminds me of Bethoven
IP: Logged |
Today’s Price Performance as of 1:00pm EDT, 9/25/2006 Option Chains Margin Requirements Interactive Chart
Loading Chart1 Day | 5 Day | 6 Mo | 1 Yr | 3 Yr | 5 Yr $0.043 Last Price 0.0070 -14.00% Today’s Change $0.05 Today’s Open 782,769 Above Avg. Today’s Volume
-------------------- All I say is IMHO.
I like these calm little moments before the storm... Reminds me of Bethoven
IP: Logged |
posted
this news should boost Calbatechs plans since they are hooked deep into Medspas Solena
Spas Tuesday October 17, 12:13 pm ET
Partnership Targets 50 Locations Nationwide
ATLANTA, GA--(MARKET WIRE)--Oct 17, 2006 -- MedSpas of America, Inc. (Other OTC:MDSP.PK - News), www.medspasofamerica.com, today announces that it has signed a Joint Venture Development Agreement with Solana MedSpas of Irvine, California.
Under the terms of the MedSpa Development Joint Venture, Solana MedSpas has agreed to provide development services and operational oversight to MDSP with the intent to build a company owned chain of a minimum of 50 Medical Spas, under the brand name of Virtuoso Medical Spas, in the United States over the next 5 years. The services provided by Solana will include site selection and build-out of new MedSpas, design services, equipment and supplies procurement, medical protocol and operating systems, recruitment and training of MedSpa staffing, medical regulatory compliance, and marketing programs. Both Solana MedSpas and MSAP have agreed to focus the company's initial development program on the acquisition and conversion of existing MedSpa businesses that are not currently in the national Solana MedSpas network.
Paul R. Smith, CEO of MDSP, said: "The experience that Solana's management team has in developing MedSpas is unprecedented in the industry. Our joint venture with Solana MedSpas brings incredible depth into our management team. The systems and expertise Solana MedSpas provides will accelerate our growth and minimize our mistakes along the way. I am very proud that a company with the reputation of Solana MedSpas has joined forces with us."
"We are delighted to be partnering with MDSP! Their business plan and strong financial resources enable Solana MedSpas to accelerate its business plan to add new MedSpa locations across the U.S. at a faster rate," said John Buckingham, Chairman, CEO and Co-Founder of Solana MedSpas.
About Solana MedSpas
Founded in July 2003, Solana MedSpas has created a new market segment by combining aesthetic healthcare in conjunction with the spa movement, coming from the medical, regulatory and educational approach. Moving beyond aesthetic medical treatments, Solana MedSpas is the nation's first MedSpa network to offer a broader range of medical treatments in a retail spa environment. Solana MedSpas provides the industry's only model for a legally compliant, competitive, and forward-thinking business in all 50 states.
Solana MedSpas has 30 Medical Spas open to date and another 20 slated to open by end of year 2006 in 21 states representing 50 trade areas. Solana MedSpas plans to grow the network to a total of 100 locations by 2007. For more information on Solana MedSpas call 949-223-6444 or visit www.solanamedspas.com
About MedSpas of America, Inc.
MedSpas of America, Inc., www.medspasofamerica.com, is dedicated to the development and operations of MedSpas throughout the United States under the brand name of Virtuoso Medical Spas. Virtuoso was founded by leading practitioners and accomplished executives in response to the growing marketplace demand for technology-based medical spa facilities that are committed to professional skin care.
This press release contains forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not guarantees of future performance. Such statements are subject to risks and uncertainties and other factors as may be discussed from time to time in the Company's public filings with the U.S. Securities and Exchange Commission ("Commission"), press releases and verbal statements that may be made by our officers, directors or employees acting on our behalf which could cause actual results to differ materially from those discussed in the forward-looking statements and from historical results of operations. In addition to statements, which explicitly describe such risks and uncertainties, statements with the terms "believes," "belief," "expects," "plans," "anticipates" and similar statements should be considered uncertain and forward-looking. Factors that might cause such a difference include, without limitation: the uncertainty of the Company's ability to meet capital needs and as further set forth in our public filings filed with the Commission and our press releases.
Contact:
Investor Contact Information: 500 Australian Avenue S., Suite 700 West Palm Beach, FL 33401 Telephone: 561-514-0194 Email: Email Contact
posted
Tell you what Quest, this one is slowly climbing on little volume.
-------------------- Before you criticize someone, try walking a mile in their shoes, then when you do, you'll be a mile away and have their shoes.
IP: Logged |
posted
it don't take much for this one to run thats for sure and with the financials coming out in November and the company clearly stated they WILL BE profitable THIS year this could really explode without notice! Like to see it close the year at our predicted .50 range.
posted
GREAT NEWS!!! heres the response I just got from the other Medspa company!!
here's the e-mail I sent...
I noticed your news today....congrats! I was wondering if your company will also be getting involved with Calbatech (CLBE) as Solena Medspas is and the adult stem cell banking, if so that to will be great for all companies involved!
have a good one!
Hank
heres the response!!!
Hank
Yes we will be getting involved with Calbatech under the Solana umbrella.
posted
After contacting IR I believe we will get a PR to include Medspas of America under our umbrella now! With a company statement already saying we will be profitable THIS year and with the under=estimated rev projections I believe CLBE is going to get right on the high road soon.
Everyone expects political commercials to oversimplify things, but American commercials dealing with stem cell research make mere oversimplification look like a PhD dissertation. Scepticism that therapeutic cloning might not deliver the goods is interpreted as despicable Pharisaism.
In the weeks before the November 7 elections, the most egregious example of dumbed-down argument uses three actors. There's a teenaged boy who says he might get paralysed in a car accident, a young woman who worries about getting Alzheimer's, and a little girl who pouts that she might get diabetes. "Maybe I'm your mother. Maybe I'm your grandson. Maybe I'm your little girl... How come he think he gets to decide who lives and who dies? Who is he?" It's cloyingly, shamefully, deceitfully emotional, uncontaminated by a smidgen of fact, the medical counterpart of the notorious Willie Horton commercials which sank Michael Dukakis in the 1988 presidential election. But it works.
It works so well, in fact, that it is being used in not one, but four states. A Democratic lobby group, Majority Action, is using it to "turn a powerful spotlight" on four members of the House of Representatives: Jim Walsh, of New York; Chris Chocola, of Indiana; Doug Sherwood, of Pennsylvania; and Thelma Drake, of Virginia. Majority Action spokesman Mark Longabaugh, says that "stem cell research offers great medical hope for patients and families suffering from devastating illness or injuries. This ad, in very powerful terms, lays out what is at stake in the stem cell debate... Republicans have made choices that pick ideology over life-saving medical research."
The only problem is that this medical research hasn't actually saved any lives and may never save any. [SIZE="4"]In fact, the smart money is on adult stem cells[/SIZE]. As Associate Professor James Sherley, of the Massachusetts Institute of Technology, wrote last week: "Despite similar misinformation to the contrary, adult stem cell research is a viable and vibrant path to new medical therapies. Even calling them an alternative to embryonic stem cells misinforms the public. Why? Because embryonic stem cells provide no path at all. " Even scientists who are ardent supporters of the research have acknowledged that useful products from embryonic stem cells are at least 15 years away. And no one has ventured to guess how much these cures might cost.
Distorted as they may be, something can be learned from ads like these. Take this one from a Congressional race in Wisconsin designed to kneecap Republican John Gard. The music is a bit odd -- what does Enya have to do with stem cells? -- but the ad is quite effective. It cites Republican favourites like Orrin Hatch and Nancy Reagan who back the research, juxtaposing them with Darth Vaders from "the extreme right" like disgraced Congressman Tom Delay, TV evangelist Pat Robertson and Focus on the Family president James Dobson. Gard's ethical reservations would stifle hope for a range of diseases, the ad suggests. These include Alzheimer's, which most scientists acknowledge is probably beyond stem cell cures.
This ad employs clever rhetorical jiujutsu to trip up opponents with the force of their own arguments. Dobson, for instance, is quoted as saying, "Lowering that standard is also likely to lead to human cloning and harvesting of body parts conceived for this purpose." But thumping the drum of doom doesn't work; it only makes him look ridiculous, at least to viewers in the Badger State.
Similarly, the Wisconsin race for governor pits incumbent Jim Doyle against Mark Green, who this woman says is "too extreme" for the job because he opposes stem cell research. (Governor Doyle, on the other hand, is extremely generous. He recently handed over US$1 million to a private company started by the scientist who first isolated human embryonic stem cells, James Thompson.)
Extremism in defence of embryos may be no vice, but it is not necessarily effective. What Dobson says could come to pass, but what he foresees is only on the radar of the best-informed participants in the debate. Meanwhile, his opponents simply ridicule him as Chicken Little.
posted
New leukemia stem cell method cuts risks NASHVILLE, Oct. 17 (UPI) -- U.S. researchers at St. Jude Children's Research Hospital say they have an improved blood stem cell method for pediatric leukemia.
The new technique is particularly promising for children who have failed on standard leukemia treatments, they said Tuesday.
The new method allows blood stem cells to come from parents or unmatched adult siblings without the usual toxicity risk, so larger number of patients with leukemia or with non-cancerous blood disorders can be candidates for a stem cell transplant, said Gregory Hale, interim chief of the St. Jude Bone Marrow Transplantation Division.
"The overall success of this procedure suggests it holds promise for children who are likely to fail standard treatment for leukemia because they have treatment-resistant disease and no matched donor," Hale said.
The key to the procedure -- called reduced intensity conditioning regimen (RICR) -- is its ability to avoid the total-body irradiation normally used to kill the recipient's own stem cells to make way for the transplantation.
Studies of the new treatment so far show it speeds up recovery of the patient's immune system after transplant and shortened the time of immune deficiency during the early post-transplant period, reducing the risk of infections.
Researchers noted that RICR bolstered not only the immune system's T and B lymphocytes, but also its so-called natural killer cells, the so-called first responder cells, which launch the initial strike against invaders.
A report on this work appears in the prepublication edition of the British Journal of Haematology.
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
![[Eek!]](eek.gif)
